Hoth Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,845,390 over the previous period. Total operating expenses were $7,692,242.
Profit Margin
| 2017 | 0 | -2.01M | |
|---|---|---|---|
| 2018 | 0 | -2.49M | |
| 2019 | 0 | -7.69M | |
| 2020 | 0 | -7.19M | |
| 2021 | 0 | -14.31M | |
| 2022 | 0 | -11.67M | |
| 2023 | 0 | -7.84M |
HOTH Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 66.83K | 46.87M | 25.87K | 31.62K | 28.25K | 188 |
Gross profit | 0 | -66.83K | -46.87M | -25.87K | -31.62K | -28.25K | -188 |
Operating exp. | |||||||
Research and development | 3.48M | 4.93M | 7.52M | 2.88M | 2.12M | 1.01M | 586.84K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 964.32K |
Total operating expenses | 7.69M | 11.06M | 14.10M | 7.30M | 7.71M | 2.49M | 1.87M |
Operating income | -7.69M | -11.06M | -14.10M | -7.30M | -7.71M | -2.49M | -1.87M |
Other income (expenses), net | -153.14K | -306.39K | -212.26K | 104.15K | 10.36K | 0 | -143.99K |
Income before tax | -7.84M | -11.37M | -14.31M | -7.19M | -7.70M | -2.49M | -2.01M |
Income tax expense | 0 | 305.40K | -1 | -205.25K | -10.36K | 0 | 2 |
Net income | -7.84M | -11.67M | -14.31M | -7.19M | -7.69M | -2.49M | -2.01M |
Earnings per share | |||||||
Basic EPS | -2.3 | -9.75 | -16.03 | -14.56 | -20.99 | -6.62 | -5.24 |
Diluted EPS | -2.3 | -9.75 | -16.03 | -14.56 | -20.99 | -6.62 | -5.24 |
| Data source | Data source | Data source | Data source | Data source | Data source |